Document is current
Any future updates will be listed below
-
Authors
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
Suzuki, Hideaki
Huang, Jian https://orcid.org/0000-0002-3931-5013
Francis, Catherine
Wang, Shuo https://orcid.org/0000-0002-2947-8783
Tarroni, Giacomo
Guitton, Florian https://orcid.org/0000-0002-1617-6620
Aung, Nay
Fung, Kenneth https://orcid.org/0000-0001-5271-1697
Petersen, Steffen E. https://orcid.org/0000-0003-4622-5160
Piechnik, Stefan K.
Neubauer, Stefan
Evangelou, Evangelos
Dehghan, Abbas
O’Regan, Declan P. https://orcid.org/0000-0002-0691-0270
Wilkins, Martin R. https://orcid.org/0000-0003-3926-1171
Guo, Yike
Matthews, Paul M.
Rueckert, Daniel https://orcid.org/0000-0002-5683-5889
-
Funding
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/P001009/1, EP/P001009/1, EP/P001009/1)
Uehara Memorial Foundation
Japan Society for the Promotion of Science London (20K07776)
DH | National Institute for Health Research
EC | Horizon 2020 Framework Programme (825903)
British Heart Foundation (PG/14/89/31194, NH/17/1/32725, RG/19/6/34387, RE/18/4/34215, RE/18/4/34215)
Wellcome Trust (206046/Z/17/Z)
Imperial College Healthcare NHS Trust
- License Information
-
More Information
Article History
Received: 10 July 2019
Accepted: 7 July 2020
First Online: 24 August 2020
Competing interests
: S.E.P. acknowledges consultancy fees from Circle Cardiovascular Imaging. D.R. acknowledges consultancy fees from Circle Cardiovascular Imaging, Heartflow and IXICO. P.M.M. acknowledges consultancy fees from Roche, Adelphi Communications, Celgene and Biogen. He has received honoraria or speakers’ honoraria from Novartis, Biogen and Roche and has received research or educational funds from Biogen, Novartis, GlaxoSmithKline and Nodthera. He is a member of the scientific advisory board to the board of Ipsen Pharmaceuticals. The remaining authors declare no competing interests.
